Abstract
BackgroundRenal involvement affects about 50% of SLE patients accounting for significant morbidity and mortality in these patients[1]. The adipokine “Visfatin” acting as a growth factor for B-lymphocyte-precursors, exerts several proinflammatory...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
